Org.nr 979 455 518 2012 → 2013 Year-over-year analysis

ACD PHARMACEUTICALS AS: årsregnskap 2013 vs 2012

Grew 7% on revenue

approved 2014-06-30; registry 2014-09-04; journal 2014 767497

Summary

What changed

Comparing Årsregnskap 2013 with 2012 for ACD PHARMACEUTICALS AS. Revenue 7.75m NOK → 8.31m NOK (+7.2%). Equity 5.05m NOK → 3.95m NOK.

On the constructive side: revenue rose; cash rose; payroll decreased. Pressures included: equity eroded.

Also worth watching: cogs fell. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.

At a glance

Revenue

7.75m NOK 8.31m NOK

+7.2%

Equity

5.05m NOK 3.95m NOK

-21.7%

Cash

154.0k NOK 175.8k NOK

+14.1%

Total assets

9.99m NOK 10.68m NOK

+7.0%

↑
Revenue rose

Operating income / revenue moved from 7.75m NOK to 8.31m NOK (+7.2% YoY). Calculated
↑
Cash rose

Bank deposits 154.0k NOK → 175.8k NOK (+14.1% YoY). Calculated
↑
Payroll decreased

Salary cost 3.92m NOK → 2.66m NOK (51% → 32% of revenue). Calculated

↓
Equity eroded

Book equity 5.05m NOK → 3.95m NOK (equity ratio 50.6% → 37.0%). Calculated